Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals.
Coleman K, Griffin DR, Upshon PA.
Coleman K, et al.
Antimicrob Agents Chemother. 1991 Sep;35(9):1748-52. doi: 10.1128/AAC.35.9.1748.
Antimicrob Agents Chemother. 1991.
PMID: 1952842
Free PMC article.
BRL 42715 is a novel, highly potent beta-lactamase inhibitor with good activity against a broad range of beta-lactamases, including the class I enzymes of Enterobacter and Citrobacter spp. (K. Coleman, D.R.J. Griffin, J.W.J. Page, and P.A. Upshon, Antimicrob. Agents …
BRL 42715 is a novel, highly potent beta-lactamase inhibitor with good activity against a broad range of beta-lactamases, including the clas …